ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology.
Feldhaus AL, Anderson K, Dutzar B, Ojala E, McNeill PD, Fan P, Mulligan J, Marzolf S, Karasek C, Scalley-Kim M, Stewart E, Billgren J, Rubin V, Schneider K, Jurchen D, Snow K, Barnett S, Bengtsson B, Baker B, Latham JA, Allison D, Garcia-Martinez LF.
Feldhaus AL, et al. Among authors: marzolf s.
Endocrinology. 2017 Jan 1;158(1):1-8. doi: 10.1210/en.2016-1455.
Endocrinology. 2017.
PMID: 27906551